Latest News & Features
Big Pharma
The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller. 5 July 2022
article
The dispute centres on a process for extracting CBD from cannabis plant material, which anticipates the use of CBD as an anti-epileptic treatment. 5 July 2022
Big Pharma
The UK Supreme Court ruling involving Pfizer and Flynn is important for any company considering an appeal against the regulator, say Sophie Lawrance and James Batsford of Bristows. 30 June 2022
Big Pharma
Bristol-Myers Squibb claims violations under the Hatch-Waxman Act in an attempt to shut down generic. 30 June 2022
Big Pharma
Justice Mellor was unconvinced by arguments that Teva could have cleared the way. 30 June 2022
article
Many jurisdictions provide patent term extensions or Supplementary Protection Certificates in recognition of the fact that the time taken to achieve regulatory approval for patented products can often delay their release into the market. 30 June 2022
Big Pharma
Pfizer is facing a lawsuit centring on its COVID-19 antiviral, Paxlovid, after Enanta Pharmaceuticals filed a complaint citing patent infringement. 28 June 2022
Americas
Drugmaker Genus Lifesciences and pharmaceutical company Mallinckrodt have agreed to settle their trade secret dispute related to a cocaine hydrochloride formulation. 28 June 2022
Big Pharma
India-based Dr Reddy’s has ended its litigation with Indivior and Aquestive Therapeutics over a generic version of opioid addiction treatment Suboxone sublingual film. 27 June 2022
article
The COVID-19 IP agreement promises to enable developing countries more autonomy to produce and distribute vaccines, but it has attracted many critics, finds Sarah Speight. 23 June 2022